Management of type 1 diabetes mellitus

Simon R. Heller

in Oxford Textbook of Endocrinology and Diabetes

Second edition

Published on behalf of Oxford University Press

Published in print July 2011 | ISBN: 9780199235292
Published online July 2011 | e-ISBN: 9780199608232 | DOI:

Series: Oxford Textbooks

Management of type 1 diabetes mellitus

More Like This

Show all results sharing this subject:

  • Endocrinology and Diabetes


Show Summary Details


Almost 90 years after the discovery of insulin, people with type 1 diabetes still use subcutaneous insulin to manage their condition. Such treatment is life saving, preventing early death from ketoacidosis, relieving symptoms, and reversing most of the pathophysiological features within a few weeks of diagnosis. Yet people with diabetes still die prematurely from long-term complications, and the quality of the lives of others is blighted by impaired vision, amputation, renal replacement therapy, or recurrent hypoglycaemia. Despite the clear demonstration that tight glycaemic control can delay, and perhaps prevent, both micro- and macro-vascular disease, the limitations of current therapy prevent most from achieving these levels of blood glucose control. There is now a realistic, albeit distant, prospect of a revolution in treatment, involving either cell therapy (see Chapters 13.10 and 13.11) or closed-loop technology combining continuous glucose sensing and insulin-infusion pumps (see Chapter However, for the foreseeable future, the responsibility of the diabetes professional is to assist individuals with type 1 diabetes to achieve both an optimum level of blood glucose and quality of life with best use of available methods.

Chapter.  13561 words.  Illustrated.

Subjects: Endocrinology and Diabetes

Full text: subscription required

How to subscribe Recommend to my Librarian

Buy this work at Oxford University Press »

Users without a subscription are not able to see the full content. Please, subscribe or login to access all content.